Hearings to examine China's toll on older Americans' health, finances, and security

Defense Posture and Global ThreatsSenate Aging (Special) · 2026-06-17 · 119th Congress
The Senate Special Committee on Aging held this hearing to examine how the Chinese government and Chinese-linked criminal networks harm older Americans through fentanyl trafficking, pharmaceutical supply-chain dependence, financial scams, and data collection. Begins at 0:14:04
Transcript
Highlights

Title

China's impact on older Americans' health, finances, and data security

Purpose

The Senate Special Committee on Aging held this hearing to examine how the Chinese government and Chinese-linked criminal networks harm older Americans through fentanyl trafficking, pharmaceutical supply-chain dependence, financial scams, and data collection. Witnesses from the U.S.-China Economic and Security Review Commission testified on scam centers in Southeast Asia, China's dominance of generic drug ingredients, and risks from Chinese access to Americans' health and financial data. The hearing also previewed several bipartisan bills, including the Clear Labels Act and scam-related legislation. Begins at0:14:04

Who spoke

Chair Rick Scott (R-FL)0:14:04: Opened by describing China as waging a strategic campaign against seniors through fentanyl, pharmaceutical dependence, and scams0:14:28; said China supplies over 90% of active pharmaceutical ingredients for U.S. generics and 87% of antibiotic imports0:15:240:15:54; cited $5 billion lost by Americans over 60 to scams in 20240:16:53; later questioned witnesses on fentanyl supply chains1:12:24, the Entity List1:16:54, 401(k) exposure to Chinese companies1:29:18, and closed by publicizing the committee's fraud hotline1:32:24.

Sen. Kirsten Gillibrand (D-NY), Ranking Member0:20:08: Highlighted her bipartisan National Strategy for Combating Scams Act requiring an FBI-led government-wide strategy0:20:23; warned China is racing to dominate biotechnology within a few years0:22:41; later pressed witnesses on prioritizing supply chains and DFC financing tools0:57:181:01:58, described creating Florida's Cyber Fraud Task Force as attorney general and cited $21 billion in 2025 cyber-enabled fraud losses1:06:58, and asked about AI's potential to counter scams1:24:02.

Joshua Hodges, Commissioner, U.S.-China Economic and Security Review Commission0:23:48: Testified China is using below-cost pricing to eliminate Western producers of specialty chemicals used in IV treatments and implants, with no substitute within 10-15 years0:27:04; said Chinese components in the U.S. grid could pose remote-access risks to medical equipment0:28:34; said cartels, not Beijing's president, are believed to drive fentanyl trafficking1:13:10; said investing in Chinese firms is "absolutely not" the same as investing in South Korean firms given dual-use technology risk1:29:36.

Leland Miller, Commissioner, U.S.-China Economic and Security Review Commission0:30:07: Described a data-dominance hearing showing Chinese law compels companies to hand data to the state on demand0:30:52; said scam centers occupy entire city blocks with implicit government approval0:47:21; said China's share of global pharmaceutical licensing deals has risen from 3-5% to over 40%1:17:45; warned retirees often unknowingly hold Chinese, sometimes sanctioned, companies in mutual funds with no transparency1:31:28.

Catherine Price, Commissioner, U.S.-China Economic and Security Review Commission0:35:43: Said Americans reported $17.7 billion in online scam losses in 2025, a 29% increase, with nearly a quarter stolen from those over 600:36:15; said Southeast Asian scam centers generated roughly $44 billion, about 44% of the host countries' combined GDP0:37:04; noted China's own scam losses fell 30% in 2024 as U.S. losses rose 40%0:38:28; said the committee is down two commissioners awaiting appointment1:23:38.

Chris Slevin, Commissioner, U.S.-China Economic and Security Review Commission0:41:05: Said China is executing an integrated, state-directed strategy to dominate every stage of pharmaceutical production0:41:31; said the U.S. lacks reliable data on API import volumes and dependency0:44:00; recommended government purchasing power and CHIPS Act-style financing for domestic drug manufacturing0:44:300:44:56; said the U.S. makes zero generic antibiotics domestically0:58:12.

Sen. Tommy Tuberville (R-AL)0:46:36: Questioned witnesses on whether China can be trusted on drug safety0:46:36, the structure of scam operations0:47:05, and whether China is ahead in crypto0:49:36.

Sen. Jon Husted (R-OH)0:51:13: Asked what would happen if China fully cut off pharmaceutical exports, calling it alarming0:51:38; argued the U.S. was "asleep at the wheel" letting China into the WTO and lost leverage on pharmaceuticals, rare earths, telecom, and ships0:55:11.

Sen. Ashley Moody (R-FL)1:12:21: Briefly thanked the chairman during the discussion of scam manpower1:12:21.

Key moments

Chair Scott said over 90% of prescriptions filled in America are generics whose active ingredients largely come from China and India, and for many medicines China is the only supplier0:15:240:15:54.

Price testified Americans lost $17.7 billion to online scams in 2025 (up 29% from 2024), with nearly a quarter of losses hitting citizens over 600:36:150:36:37.

Price said scam centers in Myanmar, Cambodia, and Laos generated roughly $44 billion, about 44% of those countries' combined GDP, while China's own scam losses fell 30% as U.S. losses rose 40% in the same year0:37:040:38:28.

Slevin disclosed that Commission staff spent months trying to obtain data on U.S. exposure to Chinese pharmaceutical inputs and found "nobody has that information," not even the administration or India's government0:52:320:53:02.

Miller said China's share of global pharmaceutical licensing deals has climbed from 3-5% to over 40% and could reach 70% within a few years, calling it a looming national security issue1:17:451:18:57.

Gillibrand said the FBI's Internet Crime Complaint Center recorded a jump of nearly 150,000 more complaints from 2024 to 2025 amid $21 billion in cyber-enabled fraud losses1:06:581:07:16.

Miller warned retirees are often invested in mutual funds holding sanctioned Chinese companies with no transparency, and proposed labeling funds that invest in sanctioned Chinese firms1:31:281:31:48.

Husted argued the U.S. treated pharmaceuticals as a pure "economics bucket" issue rather than national security for decades, leaving no leverage against China on pharmaceuticals, rare earths, telecom, or shipbuilding0:55:110:56:07.

Hodges said Chinese components in the U.S. energy grid could allow remote access, posing a potential medical emergency for seniors dependent on dialysis machines or cardiac devices during a power disruption0:28:340:28:55.

Miller said the credibility of China's threat to cut off pharmaceutical exports doesn't require follow-through — "it just has to be out there" — to shape U.S. decision-making in a crisis1:13:521:14:41.

Metadata

CommitteeSenate Aging (Special)
Chamber / CongressSenate · 119th Congress
Date2026-06-17
TypeOpen Hearing
Witnesses
(none listed in event metadata)
Videosenate-isvp
Transcript212 caption blocks · 10,642 words · 1:33:05 runtime
EventCongress.gov 338568